Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3063% above fair value
$4.09−0.11 (-2.62%)
Close on Nov 12, 2026Market cap $256.66MP/E –Yield 0.00%
Camp4 Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Camp4 Therapeutics's operating margin for the twelve months ending Sep 30, 2026 was -1001.1%. For fiscal 2025 it was -1502.4%, against -8142.3% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1502.4% | +6639.9 |
| FY2024 | Dec 31, 2024 | -8142.3% | +6680.2 |
| FY2023 | Dec 31, 2023 | -14822.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -738.8% | +978.3 |
| Q2 FY2026 | Jun 30, 2026 | -752.1% | +118.2 |
| Q1 FY2026 | Mar 31, 2026 | -1010.1% | +516.7 |
| Q4 FY2025 | Dec 31, 2025 | -3671.3% | −1518.8 |
| Q3 FY2025 | Sep 30, 2025 | -1717.1% | +1808.0 |
| Q2 FY2025 | Jun 30, 2025 | -870.3% | – |
| Q1 FY2025 | Mar 31, 2025 | -1526.8% | – |
| Q4 FY2024 | Dec 31, 2024 | -2152.5% | – |
| Q3 FY2023 | Sep 30, 2023 | -3525.1% | – |
See a number that looks wrong?